gc301
Gene therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2022 (NCT05567627)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Lysosomal alpha-glucosidaseSupplementation
GAA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06391736 | Phase 1/Phase 2 (Phase 2) | Apr 19, 2024 | GeneCradle Inc, People's Liberation Army of China |
| NCT05793307 | Phase 1/Phase 2 (Phase 2) | Jun 2, 2023 | GeneCradle Inc |
| NCT05567627 | N/A | Aug 1, 2022 | People's Liberation Army of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GeneCradle Inc | For profit | 2 | 2 | 1 | 2023 |
| People's Liberation Army of China | Government | 2 | 1 | 2 | 2022 |
2 organizations
Page 1 / 1